A human acute lymphoblastic leukemia line with the t(4;11) translocation as a model of minimal residual disease in SCID mice

Leukemia Research

Volumn 21, Issue 11-12, 1997, Pages 1107-1114

  Gobbi, Alberto ^a   Di Berardino, Cristina ^a,b   Scanziani, Eugenio ^b   Garofalo, Angela ^a   Rivolta, Anna ^b   Fontana, Giovanna ^b   Rambaldi, Alessandro ^c   Giavazzi, Raffaella ^a   Biondi, Andrea ^b  

^a MARIO NEGRI INST PHARMACOL RES   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c OSPEDALI RIUNITI   (Italy)

Author keywords

ALL; Leukemia; Minimal residual disease; SCID mice; t(4; 11) translocation

Indexed keywords

CYCLOPHOSPHAMIDE; IDARUBICIN; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CANCER SURVIVAL; CANCER TRANSPLANTATION; CASE REPORT; CENTRAL NERVOUS SYSTEM; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 4; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; INTRAVENOUS DRUG ADMINISTRATION; MINIMAL RESIDUAL DISEASE; MOUSE; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCID MOUSE; SPLEEN;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; CELL CYCLE; CENTRAL NERVOUS SYSTEM; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 4; CYCLOPHOSPHAMIDE; DISEASE MODELS, ANIMAL; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; LEUKEMIC INFILTRATION; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; NEOPLASM, RESIDUAL; POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC; TRANSLOCATION, GENETIC; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0031452871     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(97)00092-1     Document Type: Article

References (24)

1. Cesano, A., O'Connor, R., Lange, B., Finan, J., Rovera, G. and Santoli, D., Homing and progression patterns of childhood acute lymphoblastic leukemias in severe combined immunodeficiency mice. Blood, 1991, 77, 2463.
2. Biondi, A., Motta, T., Garofalo, A., Rossi, V., Giudici, G., Rizzo, V., Pioltelli, P., Corneo, G., Barbui, T., Parma, A., Rambaldi, A. and Giavazzi, R., Human T-cell lymphoblastic lymphoma expressing the T-cell receptor γ/δ established in immune-deficient (bg/nu/xid) mice. Leukemia, 1993, 7, 281.
3. Uckun, F. M., Downing, J. R., Chelstrom, L. M., Gunther, R., Ryan, M., Simon, J., Carroll, A. J., Tuel-Ahlgren, L. and Crist, W. M., Human t(4;11)(q21;q23) acute lymphoblastic leukemia in mice with severe combined immunodeficiency. Blood, 1994, 84, 859.
4. Sawyers, C. L., Gishizky, M. L., Quan, S., Golde, D. W. and Witte, O. N., Propagation of human blastic myeloid leukemias in the SCID mouse. Blood, 1992, 79, 2089.
5. Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., Minden, M., Paterson, B., Caligiuri, M. A. and Dick, J. E., A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature, 1994, 367, 645.
6. Giavazzi, R., Di Berardino, C., Garofalo, A., Motta, T., Gobbi, A., Scanziani, E., Giudici, G., Galli, M., Mayo, J. G., Barbui, T., Biondi, A. and Rambaldi, A., Establishment of human acute myelogenous leukemia lines secreting interleukin-1β in SCID mice. Int. J. Cancer, 1995, 61, 280.
7. Uckun, F. M., Severe combined immunodeficient mouse models of human leukemia. Blood, 1996, 88, 1135.
8. Ratajczak, M. Z., Kant, J. A., Luger, S. M., Hijiya, N., Zhang, J., Zon, G. and Gewirtz, A. M., In vivo treatment of human leukemia in a scid mouse model with c-myb antisense, oligodeoxynuelcotides. Proc. Nat. Acad. Sci. U.S.A., 1992, 89, 11823.
9. Jansen, B., Uckun, F. M., Jaszcz, W. B. and Kersey, J. H., Establishment of a human t(4;11) leukemia in severe combined immunodeficient mice and successful treatment using anti-CD19 (B43)-pokeweed antiviral protein immunotoxin. Cancer Res., 1992, 52, 406.
10. Gunther, R., Chelstrom, L. M., Tuel-Ahlgren, L., Simon, J., Myers, D. E. and Uckun, F. M., Biotherapy for xenografted human central nervous system leukemia in mice with severe combined imunodeficiency using B43 (anti-CD19)-pokeweed antiviral protein immunotoxin. Blood, 1995, 85, 2537.
11. Kamel-Reid, S., Letarte, M., Doedens, M., Greaves, A., Murdoch, B., Grunberger, T., Lapidot, T., Thorner, P., Freedman, M. H., Phillips, R. A. and Dick, J. E., Bone marrow from children in relapse with pre-B acute lymphoblastic leukemia proliferates and disseminates rapidly in SCID mice. Blood, 1991, 78, 2973.
12. Campana, D. and Plui, C. H., Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance. Blood, 1995, 85, 1416.
13. Biondi, A. and Rambaldi, A., Polymerase chain reaction (PCR) approach for the evaluation of minimal residual disease in acute leukemia. Stem Cells, 1994, 12, 394.
14. van der Does-van den Berg, A., Bartram, C. R., Basso, G., Benoit, Y. C. M., Biondi, A., Debatin, K.-M., Haas, O. A., Harbott, J., Kamps, W. A., Koller, U., Lampert, F., Ludwig, W.-D., Nierneyer, C. M. and van Wering, E. R., Minimal requirements for the diagnosis, classification, and evaluation of the treatment of childhood acute lymphoblastic leukemia (ALL) in the 'BFM family' cooperative group. Med. Pediatr. Oncol., 1992, 20, 497.
15. Conter, V., Arico, M., Valsecchi, M. G., Rizzari, C., Testi, A., Messina, C., Mon, P. G., Miniero, R., Colella, R., Basso, G., Rondelli, R., Pession, A. and Masera, G., Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with BFM-based intensive chemotherapy. J. Clin. Oncol., 1995, 13, 2497.
16. Biondi, A., Rambaldi, A., Rossi, V., Elia, L., Caslini, C., Basso, G., Battista, R., Barbui, T., Mandelli, R., Masera, G., Croce, C., Canaani, E. and Cimino, G., Detection of ALL-1/AF4 fusion transcript by reverse transcription-polymerase chain reaction for diagnosis and monitoring of acute leukemias with the t(4;11) translocation. Blood, 1993, 82, 2943.
17. Cavallo, F., Forni, M., Riccardi, C., Soletti, A., Di Pierro, F. and Forni, G., Growth and spread of human malignant T lymphoblasts in immunosuppressed nude mice: a model for meningeal leukemia. Blood, 1992, 80, 1279.
18. Bleyer, W. A., Biology and pathogenesis of CNS leukemia. Am. J. Pediatr. Hematol. Oncol., 1989, 11, 57.
19. Pui, C.-H., Frankel, L. S., Carrol, A. J., Raimondi, S. C., Shuster, J. J., Head, D. R., Crist, W. M., Land, V. J., Pullen, D. J., Steuber, C. P., Belim, F. G. and Borowitz, M. J., Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11) (q2 1;q23): a collaborative study of 40 cases. Blood, 1991, 77, 440.
20. Gianni, A. M., Bregni, M., Siena, S., Brambilla, C., Di Nicola, M., Lombardi, F., Gandola, L., Tarella, C., Pileri, A., Ravagnani, F., Valagussa, P. and Bonadonna, G., High-dose chemotherapy with autologous bone marrow transplantation compared with MACO-B in aggressive B-cell lymphoma. New Engl. J. Med., 1997, 336, 1290.
21. Tarella, C., Boccadoro, M., Omedè, P., Bondesan, P., Caracciolo, D., Frieri, R., Bregni, M., Siena, S., Gianni, A. M. and Pileri, A., Role of chemotherapy and GM-CSF on hemopoietic progenitor cell mobilization in multiple myeloma. Bone Marrow Transplant, 1993, 11, 271.
22. Larson, R. A., Dodge, R. K., Burns, C. P., Lee, E. J., Stone, R. M., Schulman, P., Duggan, D., Davey, F. R., Sobol, R. E., Frankel, S. R., Hooberman, A. L., Westbrock, C. A., Arther, D. C., George, S. L., Bloomfield, C. D. and Schiffer, C. A., A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia Group B Study 8811. Blood, 1995, 85, 2025.
23. Skipper, H. E., Schabel, F. M. and Wilcox, W. S., Experimental evaluation of potential anticancer agents. On the criteria and kinetics associated with 'curability' of experimental leukemia. Cancer Treatment Rep., 1964, 34, 1.
24. Cimino, G., Elia, L., Rivolta, A., Rapanotti, M. C., Rossi, V., Alimena, G., Annino, L., Canaani, E., Lo Coco, F. and Biondi, A., Clinical relevance of residual disease monitoring by polymerase chain reaction in patients with ALL-1/ AF-4 positive-acute lymphoblastic leukemia. Br. J. Haematol., 1996, 92, 659.